A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting

M Hussain1, A Melegaro, R G Pebody

  • 1Immunisation Department, Communicable Disease Surveillance Centre, Health Protection Agency Centre for Infections, London, UK.

Epidemiology and Infection
|September 27, 2005
PubMed

Insights

Streptococcus pneumoniae nasopharyngeal carriage was common in UK pre-school children before the 7-valent pneumococcal conjugate vaccine (PCV). PCV could cover most serotypes, but monitoring non-vaccine types is crucial.

Area of Science:

  • Pediatric infectious diseases
  • Microbiology
  • Epidemiology

Background:

  • Nasopharyngeal carriage of Streptococcus pneumoniae (pneumococcus) is a key factor in transmission.
  • Understanding carriage prevalence and serotype distribution is vital for vaccine impact assessment.

Purpose of the Study:

  • To assess the prevalence and serotype distribution of pneumococcal carriage in a UK household setting prior to widespread conjugate vaccine use.
  • To evaluate the potential impact of the 7-valent pneumococcal conjugate vaccine (PCV) on carriage.

Main Methods:

  • A 10-month longitudinal household study in Hertfordshire, England (2001-2002).
  • Monthly collection of epidemiological data and nasopharyngeal swabs from 121 families (489 individuals).
  • Standard pneumococcal culture methods and serotyping.

Main Results:

  • Mean carriage prevalence varied by age: 52% (0-2 yrs), 45% (3-4 yrs), 21% (5-17 yrs), 8% (≥18 yrs).
  • Young children (0-2 yrs) were primary introducers of new serotypes into households.
  • PCV was estimated to cover 64% of serotypes without cross-protection and 82% with cross-protection.
  • Antibiotic resistance: 10% erythromycin resistance, 3.7% penicillin non-susceptibility.

Conclusions:

  • Pneumococcal nasopharyngeal carriage was highly prevalent in UK pre-school children before PCV introduction.
  • PCV demonstrated potential to cover a significant proportion of circulating pneumococcal serotypes.
  • Long-term monitoring of non-vaccine serotypes post-PCV introduction is recommended.

Related Concept Videos

Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...